SCLERODERMA is a condition that results in hard, thickened areas of skin. Although it is relatively uncommon, it can sometimes cause problems with internal organs and ...

Researchers found a unique immune cell plays a key role in the chronic inflammation and scarring in the lungs and skin of people with scleroderma, or systemic sclerosis. After injecting mice with ...

Georgina has diffuse systemic scleroderma, a rare condition that causes the hardening and tightening of skin alongside affecting the internal organs (Picture: Georgina Pantano) Since Georgina Pantano, ...

A team of researchers at the Medical University of South Carolina (MUSC) has found that the molecule lysyl oxidase (LOX) plays a number of important roles in promoting skin and organ fibrosis in ...

Sanofi will be the inaugural partner for the Scleroderma Research Foundation’s new clinical trial initiative to advance treatments for the rare autoimmune disorder of the skin and organs. The ...

Please provide your email address to receive an email when new articles are posted on . The last 3 years of drug development in scleroderma have come to represent everything that ails the current ...

Epigenetic drugs that have shown promise in cancer trials significantly reduce scarring in the cells of patients with scleroderma, a new study shows. Results reveal that drugs that inhibit BRD4, known ...

Please provide your email address to receive an email when new articles are posted on . Rheumatologists are likely to be at the “forefront” of diagnosing scleroderma skin disorders and other ...

A new 3D tissue model may pave the way for better treatments for the 300,000 Americans affected by scleroderma, a rare immune disease that scars and hardens tissues in the skin and vital organs like ...